Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis
The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …
[HTML][HTML] SLE classification criteria: Is “The causality principle” integrated and operative–and do the molecular and genetical network, on which criteria depend on …
OP Rekvig - Autoimmunity Reviews, 2023 - Elsevier
Molecular and cellular aspects of the autoimmune pathophysiology in SLE is linked to the
“The causality principle”. SLE Classification Criteria identify per definition disease measures …
“The causality principle”. SLE Classification Criteria identify per definition disease measures …
PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
Systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE) of the skin are
autoimmune diseases characterized by inappropriate immune responses against self …
autoimmune diseases characterized by inappropriate immune responses against self …
Diagnostic test accuracy of novel biomarkers for lupus nephritis—An overview of systematic reviews
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with
multiorgan inflammatory involvement and a mortality rate that is 2.6-fold higher than …
multiorgan inflammatory involvement and a mortality rate that is 2.6-fold higher than …
Pericarditis in systemic rheumatologic diseases
A Kontzias, A Barkhodari, QP Yao - Current Cardiology Reports, 2020 - Springer
Abstract Purpose of Review We review the epidemiology, pathophysiology, and
management of pericarditis most commonly complicating autoimmune and autoinflammatory …
management of pericarditis most commonly complicating autoimmune and autoinflammatory …
[HTML][HTML] Pericarditis in lupus
Pericarditis is a common cardiac manifestation in systemic lupus erythematosus (SLE).
Serositis is recognized in the ACR, SLICC, and EULAR/ACR classification criteria. We …
Serositis is recognized in the ACR, SLICC, and EULAR/ACR classification criteria. We …
Amentoflavone ameliorates carrageenan-induced pleurisy and lung injury by inhibiting the NF-κB/STAT3 pathways via Nrf2 activation
T Hou, M Yang, K Yan, X Fan, X Ci… - Frontiers in …, 2022 - frontiersin.org
Many natural flavonoids can activate nuclear factor erythroid 2-related factor 2 (Nrf2), which
is pivotal for alleviating various diseases related to inflammation and oxidative stress …
is pivotal for alleviating various diseases related to inflammation and oxidative stress …
Pulmonary manifestations of systemic lupus erythematosus and Sjögren's syndrome
ML Velazquez, KB Highland - Current Opinion in Rheumatology, 2018 - journals.lww.com
Although further research into treatment strategies for the pulmonary complications seen in
SLE and pSS is needed, the clinician should be aware of the risk factors and clinical …
SLE and pSS is needed, the clinician should be aware of the risk factors and clinical …
Autoimmune pericarditis: multimodality imaging
G Goldar, C Garraud, AA Sifuentes, H Wassif… - Current Cardiology …, 2022 - Springer
Abstract Purpose of the Review The purpose of this review is to understand the underlying
mechanism that leads to pericarditis in systemic autoimmune and autoinflammatory …
mechanism that leads to pericarditis in systemic autoimmune and autoinflammatory …
Cardiac manifestations in systemic lupus erythematosus: clinical correlates of subclinical echocardiographic features
AAA Mohamed, N Hammam… - BioMed Research …, 2019 - Wiley Online Library
Objectives. This study aims to correlate subclinical echocardiographic features with the
clinical, laboratory, and therapeutic profiles of the patients to characterize risks for systemic …
clinical, laboratory, and therapeutic profiles of the patients to characterize risks for systemic …